Acute Schizophrenia Episode

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Acute Schizophrenia Episode trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06687694

Immune Mechanisms of Antipsychotic Treatment Response

The aim of this study is to investigate the role of the immune system in psychotic symptoms and their response to treatment. The investigators will collect bloo…

United Kingdom500 participantsStarted 2025-08-06

All recent trials (25 shown)

CompletedPhase 2

NCT03055338

An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005)

This will be a randomized, placebo-controlled, parallel-group, multi-site, double-blind trial of elpipodect compared with placebo, using Risperidone as an activ…

United States224 participantsStarted 2017-03-08

Treatment: Elpipodect, Risperidone

CompletedPhase 2

NCT04624243

Efficacy and Safety of Elpipodect (MK-8189) in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

The purpose of this study was to evaluate the efficacy and safety of elpipodect at a range of doses (8 mg, 16 mg, and 24 mg once daily \[QD\]) in adult particip…

United States499 participantsStarted 2020-12-15

Treatment: Elpipodect, Risperidone

Acute Schizophrenia Episode

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Immune Mechanisms of Antipsychotic Treatment Response

All recent trials (25 shown)

An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005)

Efficacy and Safety of Elpipodect (MK-8189) in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Immune Mechanisms of Antipsychotic Treatment Response

All recent trials (25 shown)

An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005)

Efficacy and Safety of Elpipodect (MK-8189) in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health

The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis

Feasibility of a Novel Process-based Treatment for Patients With Psychosis

SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities

Study Evaluating the Efficacy and Safety of WID-RGC20(Cariprazine) in Patients With Schizophrenia

Pharmacologic Treatment of Acute Episode of Schizophrenia: a Real World Study

Copeptin in Outcome Prediction of an Acute Psychotic Episode

Evaluating the Efficacy of a Late-Life Schizophrenia Integrated Care Pathway to Treat Acute Psychotic Symptoms

A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexib…

A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia

Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode

Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia

Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia

Multicenter, Open-Label, Randomised, Haloperidol-controlled Study to Evaluate Seroquel as Mono-Therapy in the Treatment…

Efficacy and Safety of Quetiapine Fumarate in the Treatment of Schizophrenic Patients

A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bip…

A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipol…

A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder